Style | Citing Format |
---|---|
MLA | Sm Khajeh Somaiyeh MARGHOUB, et al.. "Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period." Journal of Research on History of Medicine, vol. 14, no. 2, 2025, pp. 133-154. |
APA | Sm Khajeh Somaiyeh MARGHOUB, R Saghebi ROSHANAK, J Rezaeiorimi JAMAL, M Mojahedi MORTEZA, F Ghaffari FARZANEH (2025). Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period. Journal of Research on History of Medicine, 14(2), 133-154. |
Chicago | Sm Khajeh Somaiyeh MARGHOUB, R Saghebi ROSHANAK, J Rezaeiorimi JAMAL, M Mojahedi MORTEZA, F Ghaffari FARZANEH. "Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period." Journal of Research on History of Medicine 14, no. 2 (2025): 133-154. |
Harvard | Sm Khajeh Somaiyeh MARGHOUB et al. (2025) 'Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period', Journal of Research on History of Medicine, 14(2), pp. 133-154. |
Vancouver | Sm Khajeh Somaiyeh MARGHOUB, R Saghebi ROSHANAK, J Rezaeiorimi JAMAL, M Mojahedi MORTEZA, F Ghaffari FARZANEH. Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period. Journal of Research on History of Medicine. 2025;14(2):133-154. |
BibTex | @article{ author = {Sm Khajeh Somaiyeh MARGHOUB and R Saghebi ROSHANAK and J Rezaeiorimi JAMAL and M Mojahedi MORTEZA and F Ghaffari FARZANEH}, title = {Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period}, journal = {Journal of Research on History of Medicine}, volume = {14}, number = {2}, pages = {133-154}, year = {2025} } |
RIS | TY - JOUR AU - Sm Khajeh Somaiyeh MARGHOUB AU - R Saghebi ROSHANAK AU - J Rezaeiorimi JAMAL AU - M Mojahedi MORTEZA AU - F Ghaffari FARZANEH TI - Investigation of Pharmaceutical Developments in Fars Province in Iran During the First Pahlavi Period JO - Journal of Research on History of Medicine VL - 14 IS - 2 SP - 133 EP - 154 PY - 2025 ER - |